Evidence map›Paper›PMID 32664455›Full record

ArticleDiagnostics (Basel, Switzerland)2020

Diagnostic Ability of Structural Transcranial Sonography in Patients with Alzheimer's Disease.

Daiva Rastenyte, Vaidas Matijosaitis, Ovidijus Laucius, Rymante Gleizniene, Simonas Jesmanas, Kristina Jureniene

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Daiva RastenyteDepartment of Neurology, Medical Academy, Lithuanian University of Health Sciences, A. Mickevičiaus Str. 9., LT-44307 Kaunas, Lithuania.ORCID 0000-0002-5603-2357
Vaidas MatijosaitisDepartment of Neurology, Medical Academy, Lithuanian University of Health Sciences, A. Mickevičiaus Str. 9., LT-44307 Kaunas, Lithuania.
Ovidijus LauciusDepartment of Neurology, Medical Academy, Lithuanian University of Health Sciences, A. Mickevičiaus Str. 9., LT-44307 Kaunas, Lithuania.
Rymante GleiznieneDepartment of Radiology, Medical Academy, Lithuanian University of Health Sciences, A. Mickevičiaus Str. 9., LT-44307 Kaunas, Lithuania.ORCID 0000-0002-5206-3033
Simonas JesmanasDepartment of Radiology, Medical Academy, Lithuanian University of Health Sciences, A. Mickevičiaus Str. 9., LT-44307 Kaunas, Lithuania.
Kristina JurenieneInstitute of Cardiology, Medical Academy, Lithuanian University of Health Sciences, A. Mickevičiaus Str. 9., LT-44307 Kaunas, Lithuania.

Funding

Lietuvos Mokslo Taryba MIP-17-457
6 · The paper itself

Abstract

The aim of this study was to assess the diagnostic ability of transcranial sonography (TCS) for the evaluation of the medial temporal lobe (MTL) in Alzheimer's disease (AD). Standard neuropsychological evaluation, TCS and 1.5 T MRI were performed for 20 patients with AD and for 20 age- and sex-matched healthy controls in a prospective manner. Measurements of the size of the third ventricle and heights of the MTL (A) and the choroidal fissure (B) were performed twice on each side by two independent neurosonologists for all participants. On MRI, both conventional and volumetric analyses of the third ventricle and hippocampus were performed. Receiver operating characteristic (ROC) curves analyses were applied. Height of the MTL on TCS had sensitivities of 73.7% (right)/63.2%(left) and specificities of 65% (right)/65-70% (left) Area under a curve (AUC) 75.4-77.2% (right), 60.4-67.8% (left)) for AD. A/B ratio on TCS had sensitivities of 73.7% (right)/57.9% (left) and specificities of 70.0% (right)/55.0% (left) (AUC 73.3% (right), 60.4% (left)) by the experienced neurosonologist, and sensitivities of 78.9% (right and left) and specificities of 60.0% (right)/65.0% (left) (AUC 77.8-80.0%) by the inexperienced neurosonologist for AD. On MRI, linear measurement of the hippocampus and parahippocampal gyrus height had sensitivities of 84.2% (right)/89.5% (left) and specificities of 80.0% (right)/85% (left) (AUC 86.1-92.9%) for AD. Hippocampal volume had sensitivities of 70% (right and left) and specificities of 75% (right)/80% (left) (AUC 77.5-78%) for AD. Atrophy of the right MTL in AD could be detected on TCS with a good diagnostic ability, however MRI performed better on the left.

Indexed as

Alzheimer’s diseasemagnetic resonance imagingmedial temporal lobetranscranial sonographyvolumetry

Identifiers

PMID32664455
PMCPMC7400014

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.